Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 7, 2016; 22(45): 9984-9993
Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.9984
Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.9984
Figure 2 Kaplan-Meier curves of progression-free survival (A, B) and overall survival (C, D) of colorectal cancer patients.
Comparison between patients stratified on fasting HbA1c quartiles. First quartile (Q1): ≤ 5.3%; second quartile (Q2): > 5.3% and ≤ 5.7%; third quartile (Q3): > 5.7% and ≤ 6.1%; fourth quartile (Q4): > 6.1%. A, C: Overall population; B, D: Non-diabetic patients.
- Citation: Ferroni P, Formica V, Della-Morte D, Lucchetti J, Spila A, D'Alessandro R, Riondino S, Guadagni F, Roselli M. Prognostic value of glycated hemoglobin in colorectal cancer. World J Gastroenterol 2016; 22(45): 9984-9993
- URL: https://www.wjgnet.com/1007-9327/full/v22/i45/9984.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i45.9984